Boyette-DavisJACataJPDriverLC (2013) Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine. Cancer Chemotherapy and Pharmacology71(3): 619–626.
2.
HershmanDLLacchettiCDworkinRH (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology32(18): 1941–1967.
3.
KautioALHaanpaaMKautiainenH (2011) Burden of chemotherapy-induced neuropathy – a cross-sectional study. Supportive Care in Cancer19(12): 1991–1996.
4.
LoprinziCLReevesBNDakhilSR (2011) Natural history of paclitaxel-associated acute pain syndrome: Prospective cohort study NCCTG N08C1. Journal of Clinical Oncology29(11): 1472–1478.
5.
StubblefieldMDBursteinHJBurtonAW (2009) NCCN task force report: Management of neuropathy in cancer. Journal of the National Comprehensive Cancer Network7(Suppl 5): S1–S26; quiz S7–8.
